{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:15:14Z","timestamp":1784297714340,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04416-2","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T01:43:34Z","timestamp":1768959814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-4195","authenticated-orcid":false,"given":"Costantino","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-3826","authenticated-orcid":false,"given":"Luisa","family":"Di Sciascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-1115","authenticated-orcid":false,"given":"Francesca","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8560-1925","authenticated-orcid":false,"given":"Agnese","family":"Orsatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Grillini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-3631","authenticated-orcid":false,"given":"Veronica","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6476-6871","authenticated-orcid":false,"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-0374","authenticated-orcid":false,"given":"Federico Mineo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-6025","authenticated-orcid":false,"given":"Francesco","family":"Vasuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-1391","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-1838","authenticated-orcid":false,"given":"Nuno Tiago","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3931-0443","authenticated-orcid":false,"given":"Fernanda","family":"Fernandes-Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-5911","authenticated-orcid":false,"given":"Andres Martin","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-150X","authenticated-orcid":false,"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"4416_CR1","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and male genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 8). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/36"},{"key":"4416_CR2","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer, New York, USA","edition":"8"},{"issue":"1","key":"4416_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/PAS.0b013e3182a2926e","volume":"38","author":"I Alvarado-Cabrero","year":"2014","unstructured":"Alvarado-Cabrero I, Hern\u00e1ndez-Toriz N, Paner GP (2014) Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis. Am J Surg Pathol 38(1):111\u2013118","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4416_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0002-9343(86)90255-X","volume":"81","author":"CJ Logothetis","year":"1986","unstructured":"Logothetis CJ, Samuels ML, Selig DE et al (1986) Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med 81(2):219\u2013228","journal-title":"Am J Med"},{"issue":"2","key":"4416_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-014-0430-0","volume":"17","author":"MJ Reilley","year":"2015","unstructured":"Reilley MJ, Pagliaro LC (2015) Testicular choriocarcinoma: a rare variant that requires a unique treatment approach. Curr Oncol Rep 17(2):2","journal-title":"Curr Oncol Rep"},{"key":"4416_CR6","doi-asserted-by":"publisher","unstructured":"(1997) International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15(2):594\u2013603. https:\/\/doi.org\/10.1200\/JCO.1997.15.2.594","DOI":"10.1200\/JCO.1997.15.2.594"},{"issue":"8","key":"4416_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/PAS.0000000000001088","volume":"42","author":"O Hassan","year":"2018","unstructured":"Hassan O, Epstein JI (2018) The clinical significance of a small component of choriocarcinoma in testicular mixed germ cell tumor (MGCT). Am J Surg Pathol 42(8):1113\u20131120","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"4416_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","volume":"384","author":"T Powles","year":"2021","unstructured":"Powles T, Rosenberg JE, Sonpavde GP et al (2021) Enfortumab vedotin in previously treated advanced urothelial carcinoma. N Engl J Med 384(12):1125\u20131135","journal-title":"N Engl J Med"},{"issue":"22","key":"4416_CR9","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1200\/JCO.20.03489","volume":"39","author":"ST Tagawa","year":"2021","unstructured":"Tagawa ST, Balar AV, Petrylak DP et al (2021) TROPHY-U-01: a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors. J Clin Oncol 39(22):2474\u20132485","journal-title":"J Clin Oncol"},{"issue":"10","key":"4416_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2312117","volume":"390","author":"T Powles","year":"2024","unstructured":"Powles T, Valderrama BP, Gupta S et al (2024) Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. N Engl J Med 390(10):875\u2013888","journal-title":"N Engl J Med"},{"issue":"1","key":"4416_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100928","volume":"29","author":"JC Cheville","year":"2025","unstructured":"Cheville JC, Orme JJ, Gupta S et al (2025) Defining NECTIN4 amplification and protein expression in urothelial carcinoma and histologic subtypes. Mod Pathol 29(1):100928. https:\/\/doi.org\/10.1016\/j.modpat.2025.100928","journal-title":"Mod Pathol"},{"key":"4416_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105815","volume":"159","author":"B Tekin","year":"2025","unstructured":"Tekin B, Cheville JC, Milosevic D et al (2025) Assessment of trophoblast cell-surface antigen 2 (TROP2) and nectin-4 expression in choriocarcinoma. Hum Pathol 159:105815","journal-title":"Hum Pathol"},{"key":"4416_CR13","doi-asserted-by":"publisher","unstructured":"Ricci C, Ambrosi F, Franceschini T et al (2025) Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study. Virchows Arch Sep 11. https:\/\/doi.org\/10.1007\/s00428-025-04243-x. Online ahead of print","DOI":"10.1007\/s00428-025-04243-x"},{"key":"4416_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154540","volume":"247","author":"S Melotti","year":"2023","unstructured":"Melotti S, Ambrosi F, Franceschini T et al (2023) TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis. Pathol Res Pract 247:154540","journal-title":"Pathol Res Pract"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04416-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T01:43:35Z","timestamp":1768959815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04416-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":14,"alternative-id":["4416"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04416-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinicopathologic investigations were conducted according to the principles of the Declaration of Helsinki and all information regarding the human material used in this study has been managed using anonymous numerical codes. The study was approved by the local ethics committee\/CE-AVEC Bologna-Emilia Romagna (68\/2025\/Tess\/AOUBo). All patients included in the study provided informed consent, after a consultation with the investigators.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All patients included in the study provided informed consent, after a consultation with the investigators.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent if the research involved human participants"}},{"value":"The authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethics committee\/CE-AVEC Bologna-Emilia Romagna (68\/2025\/Tess\/AOUBo).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study-specific approval by the appropriate ethics committee for research involving humans and\/or animals"}}]}}